Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548622 · ClinicalTrials.gov registry record · NA
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04548622: Clinical Trial NA study, sponsored by Yale University.
NCT04548622 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04548622, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary purpose of this study was to conduct fMRI neuroimaging studies prior to and subsequent to the rTMS intervention. The intent was to ascertain changes in regional brain activation and connectivity that most robustly predict level of improvement in auditory hallucinations elicited by bilateral rTMS as assessed by the primary outcome variables.
Primary Outcome
The Positive and Negative Syndrome Scale (PANSS) is a medical scale used for measuring symptom severity of patients with schizophrenia.The PANSS positive symptoms hallucinication score has a range of 1-7. Higher scores indicate more severe positive symptoms in patients with schizophrenia.
Interventions
- DEVICE Magstim Rapid 2 system triggering Magstim Super Rapid system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-10 |
| Phase | NA |
Why NCT04548622 stopped before completion
NCT04548622 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Magstim Rapid 2 system triggering Magstim Super Rapid system is the first listed.
NCT04548622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04548622 about?
NCT04548622 is a clinical study titled "Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results". The primary purpose of this study was to conduct fMRI neuroimaging studies prior to and subsequent to the rTMS intervention. The intent was to ascertain changes in regional brain activation and connectivity that most robustly predict level of improvement in auditory hallucinations elicited by bilate...
What is the current status of trial NCT04548622?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2012-09. Estimated completion is 2016-10.
What interventions are being tested in trial NCT04548622?
The interventions under investigation include: Magstim Rapid 2 system triggering Magstim Super Rapid system (DEVICE).
Who is sponsoring clinical trial NCT04548622?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04548622's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia